Abstract
The kinetics of the antidepressant drug citalopram, a specific 5-HT uptake inhibitor, has been investigated in 11 elderly patients (age 73–90) and compared to previous data from younger patients and volunteers. The recorded steady state citalopram levels of 140–545 nM after a once-daily 20-mg dose were up to four times higher than expected from data in younger patients and volunteers. The biological half-life (1.5–3.75 days) and estimated systemic clearance (0.08–0.3 l/min) also differed from data in younger individuals (1.5 days and 0.4 l/min, respectively). Clearance values generally decreased with increasing age. Drug/metabolite ratios were higher in patients with the longest half-lives and lowest citalopram clearance, indicating reduced metabolic activity. No reduction in renal clearance was indicated by urine data, obtained for two of the patients. The study suggests that daily doses of 5–20 mg give approximately the same steady state plasma levels in elderly patients as doses of 40 mg in younger, and that this is due to reduced rates of metabolism in the elderly.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boeck V, Fredricson Overø K, Svendsen O (1982) Studies on acute toxicity and drug levels of citalopram in the dog. Acta Pharmacol Toxicol 50:169–174
Boeck V, Jørgensen A, Fredricson Overø K (1984) Comparative animal studies on cardiovascular toxicity of tri- and tetracyclic antidepressants and citalopram; relation to drug plasma levels. Psychopharmacology 82:275–281
Busse E, Simpson D (1983) Depression and antidepressants and the elderly. J Clin Psychiatry 44:5 (sec 2):35-39
Cutler NR, Zavadil AP, Eisdorfer C, Ross RJ, Potter WZ (1981) Concentrations of desipramine in elderly women. Am J Psychiatry 138:1235–1237
Dawling S, Crome P, Braithwaite RA, Lewis RR (1980) Nortriptyline therapy in elderly patients: Dosage prediction after single dose pharmacokinetic study. Eur J Clin Pharmacol 18:147–150
Fredricson Overø K (1978) Preliminary studies of the kinetics of citalopram in man. Eur J Clin Pharmacol 14:69–73
Fredricson Overø K (1981) Fluorescence assay of citalopram and its metabolites in plasma by scanning densitometry of thin layer chromatograms. J Chromatogr 224:526–531
Fredricson Overø K (1982) Kinetics of citalopram in man; plasma levels in patients. Prog Neuro-Psychopharmacol Biol Psychiatr 6:311–318
Gastpar M, Gastpar G (1982) Preliminary studies with citalopram (Lu 10-171), a specific 5-HT reuptake inhibitor, as antidepressant. Prog Neuro-Psychopharmacol Biol Psychiatr 6:319–325
Gottlieb P, Wandall T, Fredricson Overø K (1980) Initial, clinical trial of a new specific 5-HT reuptake inhibitor, citalopram (Lu 10-171). Acta Psychiatr Scand 62:236–244
Hyttel J (1982) Citalopram-Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuro-Psychopharmacol Biol Psychiatr 6:277–295
Jusko WJ, Gibaldi M (1972) Effects of change in elimination on various parameters of the two-compartment open model. J Pharm Sci 61:1270–1273
Kragh-Sørensen P, Fredricson Overø K, Lindegaard Pederson O, Jensen K, Parnas W (1981) The kinetics of citalopram: Single and multiple dose studies in man. Acta Pharmacol Toxicol 48:53–60
Kragh-Sørensen P (1983) A controlled double-blind multicentre trial comparing clomipramine and a new, highly selective 5-HT uptake inhibitor, citalopram (Lu 10-171). Abstract VIIth World Congress of Psychiatry Vienna July 11–16, 1983, p 482
Lamy P (1982) Comparative pharmacokinetic changes and drug therapy in an older population. J Am Geriat Soc 30:11:s11-s19
Lindegaard Pedersen O, Kragh-Sørensen P, Bjerre M, Fredricson Overø K, and Gram LF (1982) Citalopram, a selective serotonin reuptake inhibitor; clinical antidepressive and long-term effect — A phase II study. Psychopharmacology 77:199–204
Mertens C (1983) A controlled double-blind clinical trial of citalopram versus mianserin. Abstract VIIth World Congress of Psychiatry, Vienna July 11–16, 1983, p 441
Nies A, Robinson DS, Friedman MJ, Green R, Cooper TB, Ravaris CL, Ives JO (1977) Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry 134:790–793
Ochs HR, Verburg-Ochs B (1983) Einfuss Von Alter, Gewicht, Geschlecht- und Rauchgewohnheiten auf die Medikamentdosierung. Internist 24:167–181
Oles K (1983) Pharmacokinetics in the aged Part 1: Pharmacokinetic principles. Hospital Formulary 553–563
Schultz P, Turner-Tamiyasu K, Smith G, Giocomini KM, Blaschke TF (1984) Amitriptyline disposition in young and elderly normal men. Clin Pharmacol Ther 33:3,360–366
Thompson TL, Moran MG, Nies AS (1983) Psychotropic drug use in the elderly. New Engl J Med 308:134–138
Turbott J, Norman TR, Burrows GD, Maguire KP, Davies BM (1980) Pharmacokinetics of nortriptyline in elderly volunteers. Commun Psychopharmacol 4:225–231
Veith R (1982) Depression in the elderly: Pharmacologic considerations in treatment. J Am Geriat Soc 30:9:581–586
Øfsti E (1982) Citalopram—specific 5-HT-reuptake inhibitor—as an antidepressant drug: a phase II multicentre trial. Prog Neuro-Psychopharmacol Biol Psychiatr 6:327–335
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fredericson Overø, K., Toft, B., Christophersen, L. et al. Kinetics of citalopram in elderly patients. Psychopharmacology 86, 253–257 (1985). https://doi.org/10.1007/BF00432209
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00432209